ZimVie Inc.
Health
Performance
7.2
Risk
Sell
Buy
Curious about the Scores? Learn more.

ZimVie Inc. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

31.01.2026
Respawned at 1 HP. Still fragile, but back in play.
17.09.2025
Short-term strength kicking in. Early signs of life.
ZIMV
ZimVie Inc.
18.99
+0.00%
7.2
Sell
Buy
ZimVie Inc.

ZimVie Inc. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does ZimVie Inc. do? Business model and key facts

Get the full picture of ZimVie Inc.: what it builds, where it operates, and how it makes money.

ZimVie Inc. Profile

Sector: Healthcare

Industry: Medical - Devices

Employees (FY): 1770

ZimVie Inc., a medical technology company, develops, manufactures, and delivers a portfolio of products and solutions designed to treat a range of spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; bone grafts, barrier membranes, allografts, and collagen wound care products; intraoral scanners; and virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and patient-specific restorative components and intra-oral scanners, as well as spinal fusion implants and instrumentation for various spinal procedures, biologics, and bone healing technologies. The company also provides MIS solutions, such as Vital MIS and Timberline; and motion preservation solutions, including Mobi-C and The Tether. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.

shop
Company facts
Vafa Jamali
CEO
1770
Employees worldwide
shop
Performance
44.19%
Last 12 months
-32.18%
Last 5 years
shop
Growth
$449,75M
Revenue year
$-25.825.000
Net income
shop
Valuation
$535,63M
Market Cap
-14.80
Price/Earnings Ratio

Stocks related to ZimVie Inc.

Selected based on industry alignment and relative market positioning.

BVS
Bioventus Inc.
8.21
+1.36%
6.1
Sell
Buy
Bioventus Inc.
CTKB
Cytek Biosciences, Inc.
4.50
-8.72%
8.6
Sell
Buy
Cytek Biosciences, Inc.
VREX
Varex Imaging Corporation
13.78
-1.08%
6.1
Sell
Buy
Varex Imaging Corporation
PACB
Pacific Biosciences of California, Inc.
1.72
-12.05%
9.7
Sell
Buy
Pacific Biosciences of California, Inc.
OFIX
Orthofix Medical Inc.
12.70
-1.17%
7.2
Sell
Buy
Orthofix Medical Inc.

ZimVie Inc. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.